FOXO3 and adenocarcinoma: Among the PDAC cases, the expression levels of FOXO3a were remarkably lower in the poorly differentiated adenocarcinomas compared with those in the well and moderately differentiated adenocarcinomas (P < 0.01; Fig. 1a and Table 2).